# Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance/estimating-the-maximum-safe-starting-dose-in-initial-clinical-trials-for-therapeutics-in-adult-healthy-volunteers/a0e9555e-44bd-4cf3-bfa3-7f67f0d88a6f

> FDA guidance document: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Issue date: July 28, 2005. Get complete insights and analysis.

---

## Details

- Title: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers
- Product Type: other
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2005-07-28
- Last Changed: 2018-12-01

## Related Documents

- [Role of HIV Drug Resistance Testing in Antiretroviral Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/role-of-hiv-drug-resistance-testing-in-antiretroviral-drug-development/b63afac3-86d1-45b1-bee0-b25944c92926)
- [Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children](https://www.globalkeysolutions.net/guidances/guidance-document/orally-inhaled-and-intranasal-corticosteroids-evaluation-of-the-effects-on-growth-in-children/c4c75ea8-e4ee-4ab0-8ebb-c0191cd85f05)
- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)